Zimbabwe's emergency response to Covid-19
Enhancing access and accelerating Covid-19 testing as the first line of defense against the Covid-19 pandemic
Bibliographic Data
| ID | 22078393 |
|---|---|
| Authors | Muchaneta Gudza-Mugabe (0000-0001-5087-8821, World Health Organization - Zimbabwe, corresponding author), Kenny Sithole (Centre for Sexual Health and HIV AIDS Research), Lucia Sisya (National Blood Service Zimbabwe), Sibongile Zimuto, Sibongile N Zimuto (Zimbabwe National Quality Assurance Program), Lincoln Sunganai Charimari (World Health Organization - Zimbabwe), Anderson Chimusoro (World Health Organization - Zimbabwe), Raiva Simbi (Ministry of Health and Child Welfare), Alex Gasasira (0000-0002-1381-2732, World Health Organization - Zimbabwe) |
| Year | 2022 |
| Volume | 10 |
| Pages | 871567-871567 |
| Publication date | 2022-07-19 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.871567 |
| PMID | 35928486 |
| OpenAlex | W4285794498 |
| Language | EN |
| Citations received | 1 |
| References cited | 9 |
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spreads rapidly, causing outbreaks that grow exponentially within a short period before interventions are sought and effectively implemented. Testing is part of the first line of defense against Corona Virus Disease of 2019 (COVID-19), playing a critical role in the early identification and isolation of cases to slow transmission, provision of targeted care to those affected, and protection of health system operations. Laboratory tests for COVID-19 based on nucleic acid amplification techniques were rapidly developed in the early days of the pandemic, but such tests typically require sophisticated laboratory infrastructure and skilled staff. In March 2020, Zimbabwe confirmed its first case of COVID-19; this was followed by an increase in infection rates as the pandemic spread across the country, thus increasing the demand for testing. One national laboratory was set to test all the country's COVID-19 suspect cases, building pressure on human and financial resources. Staff burnout and longer turnaround times of more than 48 h were experienced, and results were released late for clinical relevance. Leveraging on existing PCR testing platforms, including GeneXpert machines, eased the pressure for a short period before facing the stockout of SARs-CoV-2 cartridges for a long time, leading to work overload at a few testing sites contributing to long turnaround times. On September 11, WHO released the interim guidance to use antigen rapid diagnostic test as a diagnostic tool. The Zimbabwe laboratory pillar quickly adopted it and made plans for its implementation. The National Microbiology Reference Laboratory verified the two emergency-listed kits, the Panbio Abbott and the Standard Q, Biosensor, and they met the WHO minimum performance of ≥97% specificity and ≥80% sensitivity. Decentralizing diagnostic testing leveraging existing human resources became a game-changer in improving COVID-19 containment measures. Task shifting through training on Antigen rapid diagnostic tests (Ag-RDT) commenced, and testing was decentralized to all the ten provinces, from 1 central testing laboratory to more than 1,000 testing centers. WhatsApp platforms made it easier for data to be reported from remote areas. Result turnaround times were improved to the same day, and accessibility to testing was enhanced
Disease · Medical emergency · Nucleic acid test · Operations management · Pandemic · Pathology · Personal protective equipment · Turnaround time · COVID-19 diagnosis using AI · Engineering · Medicine · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Virology
| Citations per year | 0.33 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |